General MedicationsINJECTIONGeneric
CARFILZOMIB
CARFILZOMIB
Standard Dose
30MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview CARFILZOMIB is listed in Drugs@FDA under application 209526 (ANDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient CARFILZOMIB Form and strength INJECTABLE;INJECTION - 30MG Sponsor MSN PHARMACEUTICALS INC Submission history Latest submission status date: 2023-01-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview CARFILZOMIB is listed in Drugs@FDA under application 209526 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient CARFILZOMIB Form and strength INJECTABLE;INJECTION - 30MG Sponsor MSN PHARMACEUTICALS INC Submission history Latest submission status date: 2023-01-30 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.